tezosentan has been researched along with Chronic Illness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fontoura, D; Leite-Moreira, AF; Lourenço, AP; Oliveira-Pinto, J; Roncon-Albuquerque, R; Vasques-Nóvoa, F | 1 |
| Fineman, JR; Fitzgerald, RK; Johengen, MJ; Oishi, P; Ovadia, B; Reinhartz, O; Ross, GA | 1 |
| Cheng, TO | 1 |
3 other study(ies) available for tezosentan and Chronic Illness
| Article | Year |
|---|---|
Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension.
Topics: Animals; Chronic Disease; Cytokines; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Pulmonary; Male; Neurosecretion; Nitric Oxide; Prostaglandin-Endoperoxide Synthases; Pyridines; Random Allocation; Rats; Rats, Wistar; Tetrazoles; Vasodilator Agents; Ventricular Function, Right | 2012 |
Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Disease; Animals; Animals, Newborn; Chronic Disease; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hypertension, Pulmonary; Injections, Intra-Arterial; Pulmonary Circulation; Pyridines; Random Allocation; Sheep; Tetrazoles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2004 |
Endothelin receptor blockade in congestive heart failure.
Topics: Acute Disease; Antihypertensive Agents; Bosentan; Chronic Disease; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelin-1; Exercise Tolerance; Heart Failure; Hemodynamics; Humans; Phenylpropionates; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Treatment Outcome; Vasodilator Agents | 2001 |